Mortality | ICU (n = 1286) | P | Hospital (n = 1282) | P | 30-day (n = 807) | P |
---|---|---|---|---|---|---|
(a) Patient outcomes | ||||||
No AKI AKI | 12 (6.3%) 322 (29.4%) | < 0.001 | 17 (8.9%) 350 (32.1%) | < 0.001 | 11 (18.3%) 297 (37.3%) | 0.003 |
No AKI-sCr AKI-sCr | 108 (14.0%) 226 (43.8%) | < 0.001 | 133 (17.3%) 234 (45.5%) | < 0.001 | 95 (27.0%) 195 (42.9%) | < 0.001 |
No AKI-UO AKI-UO | 33 (13.9%) 300 (28.7%) | < 0.001 | 40 (16.9%) 326 (31.3%) | < 0.001 | 28 (27.5%) 261 (37.2%) | 0.056 |
RR-AKI P-AKI | 23 (18.4%) 311 (26.8%) | 0.042 | 29 (23.2%) 338 (29.2%) | 0.158 | 22 (36.1%) 268 (35.9%) | 0.982 |
No AKD AKD | 9 (5.7%) 325 (28.8%) | < 0.001 | 11 (6.9%) 356 (31.7%) | < 0.001 | 8 (17.8%) 282 (37.0%) | 0.009 |
No KRT KRT | 263 (22.7%) 71 (56.3%) | < 0.001 | 295 (25.5%) 72 (57.1%) | < 0.001 | 232 (33.9%) 58 (47.5%) | 0.004 |
Length of stay (days) | ||||||
All No AKI AKI | 11 (5.3, 22) 5 (2.8, 7.9) 12.1 (6.7, 24) | < 0.001 | 18 (7, 34) 13.5 (6, 22) 19 (7, 36) | < 0.001 | / | / |
(b) Kidney outcomes | ||||||
AKI | 1095/1286 (85.1%) | |||||
ICU day start AKI (d) | 2 (1, 2) | |||||
ICU day AKI max (d) | 2 (2, 4) | |||||
Duration of AKI (d) | 5 (3, 9) | |||||
RR-AKI | 125 (11.4%) | |||||
AKD (n = 1286) AKD–no AKI (n = 191) AKD–AKI (n = 1095) | 1127 (87.6%) 32 (2.8% of all AKD) 1095 (97.2% of all AKD) | |||||
KRT (n = 1286) CKRT IHD | 126 (9.8%) 75 (59.5%) 51 (40.5%) | |||||
KRT start (d of ICU/date) | 7 (2, 12) | |||||
KRT end (d of ICU/date) | 17 (10, 22) | |||||
Duration KRT (d) (n = 96) | 8 (3, 14) | |||||
Kidney recovery (ICU survivors) AKI (n = 773) AKI-sCr (n = 290) AKI-UO (n = 740) AKI-UO excl KRT (n = 725) | AKI-sCr vs AKI-UO: p < 0.001 369 (47.7%) 199 (68.6%) 407 (55.0%) 397 (54.8%) | |||||
sCr@d21/ICU discharge (mg/dl) All ICU survivors (n = 952) No AKI (n = 179) AKI (n = 773) | no AKI versus AKI p = 0.266 0.73 (0.61, 0.93) 0.70 (0.65, 0.90) 0.72 (0.60, 0.95) | |||||
KRT at 21 days or ICU discharge (n = 95) | 64 (67.4%) |